Lowenstein Sandler represented FINTOP Capital in the transaction. Goodshuffle, a software company focused on the event rental and production industry, closed a $5 million Series A funding...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Costanoa Ventures in the transaction. Shepherd, a San Francisco, CA-based provider of an insurance tech platform for commercial construction, closed the $13.5 million Series...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Lakestar in the transaction. Colossyan, a London-based AI-text-to-video platform, closed its $22 million Series A funding round. The round saw participation from Lakestar,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP served as legal counsel to CIVC, while Lowenstein Sandler LLP served as legal counsel to Catalyst Investors and Datavail on the transaction....
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented 645 Ventures in the transaction. InpharmD, an Atlanta, GA-based provider of an AI-based drug information service, closed a $6.05 million Series Seed fund raise....
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced a development-and-license deal with Dr. Reddy’s Laboratories for its...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Reach Capital in the transaction. Clayful closed a $7 million fund raise, led by Reach Capital. Other Clayful investors include the Google for Startups Latino...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Avenues Global Holdings in the transaction. Avenues Global Holdings, LLC executed the sale of two of the world’s top independent schools, Avenues New...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented PVH Corp. in the transaction. PVH Corp. (NYSE:PVH) announced an agreement to sell its Warners, Olga, and True & Co. businesses to Basic...
You must be a Standard 1 Year member to access this content.
